Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage ...
Read moreWOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage ...
Read moreFREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that ...
Read moreOttawa, Ontario--(Newsfile Corp. - December 6, 2022) - KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) ...
Read moreRESEARCH TRIANGLE PARK, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. GTHX, a commercial-stage ...
Read moreSANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC, “Intevac” or “the Company”), a leading supplier of thin-film ...
Read moreWESTLAKE VILLAGE, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- SRAX, Inc. (NASDAQ: SRAX), a financial technology ...
Read moreRICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and ...
Read moreLA JOLLA, Calif.--(BUSINESS WIRE)--Sep 16, 2022--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in ...
Read moreRegister now for FREE unlimited access to Reuters.comRegisterMANILA, Sept 14 (Reuters) - The Philippines' largest casino ...
Read moreSANTA MARIA - Landec Corp. (NASDAQ: LNDC) (the 'Company') announced today that it received a notice ...
Read more© 2022 TheDailyStock.News